Sunday 18 October 2026
Export AGEN’s income statement to Excel — free account
Agenus Inc.
AGEN Healthcare Biotechnology
Agenus Inc.’s revenue for fiscal 2025 (year ended December 2025) was $114.2 million, up 10.4% from fiscal 2024. In the quarter to June 2026, revenue grew 34.4%, EPS grew 98.6%, free cash flow fell 55.3% and total debt fell 11.2%, each against the same quarter a year earlier.
6.04
0.64
−9.58%
Follow AGEN
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (33.86%) | (23.40%) | 0.03% | 12.80% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
6 | 5 | 4 | 2 | |
| 51.30% | 33.31% | (0.04%) | (14.98%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(66.19%) | (46.32%) | 0.06% | 25.79% | |
Average Days of Receivables |
151.84 | 159.31 | 22.41 | 21.40 | |
Free Cash Flow per Share |
(2.37) | (2.30) | (2.58) | (2.79) | |
Free Cash Flow |
(98.16) | (87.14) | (76.84) | (88.95) | |
Capital Expenditures |
0.35 | 0.39 | 0.35 | 0.28 | |
| Other line items | |||||
Cash ROIC |
62.50% | 53.53% | 33.38% | 36.57% | |
Accounts Receivable Turnover |
4.75 | 4.55 | 30.79 | 33.02 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.01 | 0.02 | |
Inventory Turnover |
— | — | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 29,638.21 | 27,307.44 | |
Days of Inventory on Hand |
— | — | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
43.47% | 56.22% | 69.48% | 98.85% | |
Selling, General and Administrative Expense of Revenue |
29.00% | 36.76% | 47.63% | 59.00% | |
Share Based Compensation of Revenue |
8.60% | 9.19% | 12.06% | 14.03% | |
Interest Coverage |
0.61 | 0.14 | (0.36) | (1.01) | |
Operating CF/Net income |
(1.07) | (1.36) | 764.31 | 2.52 | |
Depreciation/Fixed assets |
0.33 | 0.49 | 0.65 | 0.79 | |
Capex/Depreciation |
0.07 | 0.05 | 0.04 | 0.02 | |
Revenue per Share |
3.21 | 3.26 | 3.84 | 3.35 | |
Operating CF per Share |
(2.38) | (2.31) | (2.60) | (2.80) | |
Capex per Share |
0.01 | 0.01 | 0.01 | 0.01 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates